Fluid and total water intake in a senior mediterranean population at high cardiovascular risk: demographic and lifestyle determinants in the PREDIMED-Plus study.


Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 12 03 2019
accepted: 28 05 2019
pubmed: 4 6 2019
medline: 27 3 2021
entrez: 3 6 2019
Statut: ppublish

Résumé

We aimed to evaluate associations between compliance with recommendations for total water intake (TWI) and total water intake from fluids (TWIF), and some socio-demographic and lifestyle factors of a senior Mediterranean population at high cardiovascular risk. Cross-sectional analysis with data of 1902 participants from the PREDIMED-Plus study. A validated 32-item Spanish fluid-intake questionnaire was used to assess beverage consumption and water intake. Multivariable logistic regression models were used to assess the odds ratio (OR) and the 95% confidence interval (CI) for complying with European Food Safety Agency recommendations for TWI and TWIF according to various socio-demographic and lifestyle factors, and for the joint associations of Mediterranean diet (MedDiet) adherence and moderate-vigorous physical activity (MVPA). The mean total volume of fluid intake in the population studied was 1934 ± 617 mL/day. Water was the most frequently consumed beverage. Significant differences between sex were only observed in alcoholic and hot beverage consumption. Compliance with TWIF was associated with being women (OR 3.02; 2.40, 3.80), high adherence to MedDiet (OR 1.07; 1.02, 1.12), and participants who were more engaged in physical activity (PA) (OR 1.07; 1.02, 1.13). Age was inversely associated (OR 0.96; 0.94, 0.98). Similar results for TWI recommendations compliance were observed in relation to being women (OR 5.34; 3.85, 7.42), adherence to MedDiet (OR 1.16; 1.02, 1.31) and PA (OR 1.07; 1.00, 1.15). The joint association of PA and MedDiet, showed that participants with higher adherence to MedDiet and meeting WHO recommendations for MVPA complied better with the TWI recommendations (OR 1.66; 1.19, 2.32). High compliance with recommendations for TWI was associated with being a woman, and a healthy lifestyle characterized by high adherence to the MedDiet and PA.

Identifiants

pubmed: 31154492
doi: 10.1007/s00394-019-02015-3
pii: 10.1007/s00394-019-02015-3
doi:

Substances chimiques

Drinking Water 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1595-1606

Subventions

Organisme : Ministerio de Educación, Cultura y Deporte
ID : FPU 17/01925
Organisme : Ministerio de Educación, Cultura y Deporte
ID : FPU 16/00165
Organisme : Ministerio de Educación, Cultura y Deporte (ES)
ID : FPU 15/06147
Organisme : Instituto de Salud Carlos III (ES)
ID : PI13/00233
Organisme : Instituto de Salud Carlos III (ES)
ID : PI13/00728
Organisme : Instituto de Salud Carlos III (ES)
ID : PI13/00272
Organisme : Instituto de Salud Carlos III
ID : PI13/00462
Organisme : Instituto de Salud Carlos III
ID : PI13/01123
Organisme : Instituto de Salud Carlos III
ID : PI14/01919
Organisme : Instituto de Salud Carlos III
ID : PI14/01722
Organisme : Instituto de Salud Carlos III
ID : PI14/01374
Organisme : Instituto de Salud Carlos III
ID : PI14/00636
Organisme : Instituto de Salud Carlos III
ID : PI14/01206
Organisme : Instituto de Salud Carlos III
ID : PI16/00533
Organisme : Instituto de Salud Carlos III
ID : PI16/00501
Organisme : Instituto de Salud Carlos III
ID : PI16/00366
Organisme : Instituto de Salud Carlos III
ID : PI16/01873
Organisme : Instituto de Salud Carlos III
ID : PI16/01094
Organisme : Instituto de Salud Carlos III
ID : PI17/00926
Organisme : Instituto de Salud Carlos III
ID : PI17/00764
Organisme : Instituto de Salud Carlos III
ID : PI17/01827
Organisme : Instituto de Salud Carlos III
ID : PI17/01441
Organisme : Generalitat Valenciana (ES)
ID : PROMETEO/2017/017
Organisme : "la Caixa" Foundation
ID : 2013ACUP00194
Organisme : European Research Council ((Advanced Research Grant 2013-2018)
ID : 340918

Auteurs

Indira Paz-Graniel (I)

Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Universitat Rovira i Virgili, University Hospital of Sant Joan de Reus, IISPV, Reus, Spain.

Nancy Babio (N)

Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Universitat Rovira i Virgili, University Hospital of Sant Joan de Reus, IISPV, Reus, Spain. nancy.babio@urv.cat.
Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain. nancy.babio@urv.cat.

Luís Serra-Majem (L)

Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Research Institute of Biomedical and Health Sciences (IUIBS), Preventive Medicine Service, University of Las Palmas de Gran Canaria, Centro Hospitalario Universitario Insular Materno Infantil (CHUIMI), Canarian Health Service, Las Palmas, Spain.

Jesús Vioque (J)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Miguel Hernandez University, ISABIAL-FISABIO, Alicante, Spain.

Maria Dolores Zomeño (MD)

Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar Research Institute (IMIM), Barcelona, Spain.
Blanquerna, School of Health Sciences, Universitat Ramon Llull, Barcelona, Spain.

Dolores Corella (D)

Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, Spain.

Andrés Díaz-López (A)

Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Universitat Rovira i Virgili, University Hospital of Sant Joan de Reus, IISPV, Reus, Spain.
Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.

Xavier Pintó (X)

Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

Aurora Bueno-Cavanillas (A)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Department of Preventive Medicine, University of Granada, Granada, Spain.

Josep A Tur (JA)

Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.

Lidia Daimiel (L)

Nutritional Genomics and Epigenomics Group, IMDEA Food, CEI UAM + CSIC, Madrid, Spain.

J Alfredo Martínez (JA)

Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Nutritional Genomics and Epigenomics Group, IMDEA Food, CEI UAM + CSIC, Madrid, Spain.
Department of Nutrition, Food Science and Physiology, University of Navarra, IDISNA, Pamplona, Spain.

Nerea Becerra-Tomás (N)

Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Universitat Rovira i Virgili, University Hospital of Sant Joan de Reus, IISPV, Reus, Spain.
Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.

Eva Mª Navarrete-Muñoz (EM)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Miguel Hernandez University, ISABIAL-FISABIO, Alicante, Spain.

Helmut Schröder (H)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar Research Institute (IMIM), Barcelona, Spain.

Rebeca Fernández-Carrión (R)

Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, Spain.

Adriana Ortiz-Andrellucchi (A)

Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Research Institute of Biomedical and Health Sciences (IUIBS), Preventive Medicine Service, University of Las Palmas de Gran Canaria, Centro Hospitalario Universitario Insular Materno Infantil (CHUIMI), Canarian Health Service, Las Palmas, Spain.

Emili Corbella (E)

Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

Blanca Riquelme-Gallego (B)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Department of Preventive Medicine, University of Granada, Granada, Spain.

Laura Gallardo-Alfaro (L)

Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.

Víctor Micó (V)

Nutritional Genomics and Epigenomics Group, IMDEA Food, CEI UAM + CSIC, Madrid, Spain.

Marian Zulet (M)

Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Nutrition, Food Science and Physiology, University of Navarra, IDISNA, Pamplona, Spain.

Laura Barrubés (L)

Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Universitat Rovira i Virgili, University Hospital of Sant Joan de Reus, IISPV, Reus, Spain.
Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.

Montserrat Fitó (M)

Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Cardiovascular Risk and Nutrition Research Group (CARIN), Hospital del Mar Research Institute (IMIM), Barcelona, Spain.

Miguel Ruiz-Canela (M)

Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, IDISNA (Instituto de Investigación Sanitaria de Navarra), Pamplona, Spain.

Jordi Salas-Salvadó (J)

Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Universitat Rovira i Virgili, University Hospital of Sant Joan de Reus, IISPV, Reus, Spain. Jordi.salas@urv.cat.
Centro de Investigación Biomédica en Red Fisiopatologia de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain. Jordi.salas@urv.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH